Какова цена за MultiCell Technologies, Inc. (MCET)

Цена за MultiCell Technologies, Inc. (MCET) Это $0.00001

Какова рыночная капитализация для MultiCell Technologies, Inc. (MCET)

Рыночная капитализация для MultiCell Technologies, Inc. (MCET) Это $50.01K

MultiCell Technologies, Inc. (MCET) Дробление Акций

MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.

Год	Дробление	Коэффициент	Суммарный коэффициент
2005-05-20	1:5	x0.2	x0.0212
1992-12-01	1:10	x0.1	x0.106
1992-11-23	53:50	x1.06	x1.06

Год

Дробление

Коэффициент

Суммарный коэффициент

2005-05-20

1:5

x0.2

x0.0212

1992-12-01

1:10

x0.1

x0.106

1992-11-23

53:50

x1.06

Компания	Количество дроблений акций	Суммарный коэффициент	Страна
Novo Nordisk A/S NVO.US	5	x199	DK
Vertex Pharmaceuticals Incorporated VRTX.US	1	x2	US
Regeneron Pharmaceuticals, Inc. REGN.US	0	-	US
UCB SA UCB.BR	0	-	BE
CSL Limited CSL.AX	1	x3	AU

Компания

Количество дроблений акций

Суммарный коэффициент

Страна